BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
PRODID:-//Telerik Inc.//Sitefinity CMS 15.1//EN
BEGIN:VTIMEZONE
TZID:Eastern Standard Time
BEGIN:STANDARD
DTSTART:20251102T020000
RRULE:FREQ=YEARLY;BYDAY=1SU;BYHOUR=2;BYMINUTE=0;BYMONTH=11
TZNAME:Eastern Standard Time
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20250301T020000
RRULE:FREQ=YEARLY;BYDAY=2SU;BYHOUR=2;BYMINUTE=0;BYMONTH=3
TZNAME:Eastern Daylight Time
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DESCRIPTION:Responding to Adverse Experienced\, Post-Use Integration and Em
 erging PolicyAs psychedelic-assisted therapies move toward mainstream medi
 cine and federal policy accelerates regulatory approval\, public health pr
 ofessionals and mental health providers face new questions about crisis re
 sponse\, integration support\, access and equity.Speakers: Dessa Bergen-Ci
 co\, professor of public healthMichael Lovier\, MPH candidate Sahar Rajput
  (MAPS)
DTEND:20260501T180000Z
DTSTAMP:20260510T124028Z
DTSTART:20260501T160000Z
LOCATION:
SEQUENCE:0
SUMMARY:Psychedelics and Public Health
UID:RFCALITEM639139992286827359
X-ALT-DESC;FMTTYPE=text/html:<h3 data-placeholder="Title (100 character max
 imum)" data-sf-tooltip="input-title">Responding to Adverse Experienced\, P
 ost-Use Integration and Emerging Policy</h3><p>As psychedelic-assisted the
 rapies move toward mainstream medicine and federal policy accelerates regu
 latory approval\, public health professionals and mental health providers 
 face new questions about crisis response\, integration support\, access an
 d equity.</p><p>Speakers: </p><ul><li>Dessa Bergen-Cico\, professor of pub
 lic health</li><li>Michael Lovier\, MPH candidate </li><li>Sahar Rajput (M
 APS)</li></ul>
END:VEVENT
END:VCALENDAR